TD Cowen Maintains Outperform on Biote, Lowers Price Target to $7
Portfolio Pulse from jenniferd'souza@benzinga.com
TD Cowen analyst Brian Holland maintains an Outperform rating on Biote (NASDAQ:BTMD) but lowers the price target from $12 to $7.
August 15, 2023 | 12:17 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
TD Cowen analyst Brian Holland maintains an Outperform rating on Biote but lowers the price target from $12 to $7.
The lowering of the price target by TD Cowen from $12 to $7 indicates a potential decrease in the stock's value. Despite maintaining an Outperform rating, this adjustment could negatively impact investor sentiment and potentially lead to a short-term decrease in the stock's price.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100